China Antiandrogen Monotherapy Market Research Report Forecast 2017 to 2022
![](/report_cover/10051/china-antiandrogen-monotherapy-market-research-report-forecast-2017-to-2022_en.gif)
Delivery of the Report will take 2-3 working days once order is placed.
The China Antiandrogen Monotherapy Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Antiandrogen Monotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antiandrogen Monotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)
China Antiandrogen Monotherapy Market: Product Segment Analysis
Type 1
Type 2
Type 3
China Antiandrogen Monotherapy Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
The China Antiandrogen Monotherapy Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Antiandrogen Monotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antiandrogen Monotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)
China Antiandrogen Monotherapy Market: Product Segment Analysis
Type 1
Type 2
Type 3
China Antiandrogen Monotherapy Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Antiandrogen Monotherapy Market Segmentation by Type
1.2.1 China Production Market Share of Antiandrogen Monotherapy by Type in 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Antiandrogen Monotherapy Market Segmentation by Application
1.3.1 Antiandrogen Monotherapy Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Antiandrogen Monotherapy (2012-2021)
CHAPTER 2 CHINA ECONOMIC IMPACT ON ANTIANDROGEN MONOTHERAPY INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Antiandrogen Monotherapy Industry
CHAPTER 3 CHINA ANTIANDROGEN MONOTHERAPY MARKET COMPETITION BY MANUFACTURERS
3.1 China Antiandrogen Monotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 China Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Antiandrogen Monotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
3.5.1 Antiandrogen Monotherapy Market Concentration Rate
3.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA ANTIANDROGEN MONOTHERAPY CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)
4.1 China Antiandrogen Monotherapy Capacity, Production and Growth (2012-2017)
4.2 China Antiandrogen Monotherapy Revenue and Growth (2012-2017)
4.3 China Antiandrogen Monotherapy Production, Consumption, Export and Import (2012-2017)
CHAPTER 5 CHINA ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Antiandrogen Monotherapy Production and Market Share by Type (2012-2017)
5.2 China Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
5.3 China Antiandrogen Monotherapy Price by Type (2012-2017)
5.4 China Antiandrogen Monotherapy Production Growth by Type (2012-2017)
CHAPTER 6 CHINA ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 China Antiandrogen Monotherapy Consumption and Market Share by Application (2012-2017)
6.2 China Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS
7.1 Pfizer Inc. (USA)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Abbott Laboratories (USA)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Genentech Inc. (USA)
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 GlaxoSmithKline Plc (UK)
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Immunomedics, Inc. (USA)
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Novartis AG (Switzerland)
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 Paladin Labs Inc. (Canada)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
CHAPTER 8 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS
8.1 Antiandrogen Monotherapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antiandrogen Monotherapy
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Antiandrogen Monotherapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2017-2022)
12.1 China Antiandrogen Monotherapy Production, Revenue Forecast (2017-2022)
12.2 China Antiandrogen Monotherapy Production, Consumption Forecast by Regions (2017-2022)
12.3 China Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
12.4 China Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)
12.5 Antiandrogen Monotherapy Price Forecast (2017-2022)
CHAPTER 13 APPENDIX
1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Antiandrogen Monotherapy Market Segmentation by Type
1.2.1 China Production Market Share of Antiandrogen Monotherapy by Type in 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Antiandrogen Monotherapy Market Segmentation by Application
1.3.1 Antiandrogen Monotherapy Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Antiandrogen Monotherapy (2012-2021)
CHAPTER 2 CHINA ECONOMIC IMPACT ON ANTIANDROGEN MONOTHERAPY INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Antiandrogen Monotherapy Industry
CHAPTER 3 CHINA ANTIANDROGEN MONOTHERAPY MARKET COMPETITION BY MANUFACTURERS
3.1 China Antiandrogen Monotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 China Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Antiandrogen Monotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
3.5.1 Antiandrogen Monotherapy Market Concentration Rate
3.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA ANTIANDROGEN MONOTHERAPY CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)
4.1 China Antiandrogen Monotherapy Capacity, Production and Growth (2012-2017)
4.2 China Antiandrogen Monotherapy Revenue and Growth (2012-2017)
4.3 China Antiandrogen Monotherapy Production, Consumption, Export and Import (2012-2017)
CHAPTER 5 CHINA ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Antiandrogen Monotherapy Production and Market Share by Type (2012-2017)
5.2 China Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
5.3 China Antiandrogen Monotherapy Price by Type (2012-2017)
5.4 China Antiandrogen Monotherapy Production Growth by Type (2012-2017)
CHAPTER 6 CHINA ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 China Antiandrogen Monotherapy Consumption and Market Share by Application (2012-2017)
6.2 China Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS
7.1 Pfizer Inc. (USA)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Abbott Laboratories (USA)
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Genentech Inc. (USA)
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 GlaxoSmithKline Plc (UK)
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Immunomedics, Inc. (USA)
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 Indevus Pharmaceuticals Inc. (USA)
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Novartis AG (Switzerland)
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 OSI Pharmaceuticals, Inc. (USA)
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 Paladin Labs Inc. (Canada)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
CHAPTER 8 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS
8.1 Antiandrogen Monotherapy Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antiandrogen Monotherapy
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Antiandrogen Monotherapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2017-2022)
12.1 China Antiandrogen Monotherapy Production, Revenue Forecast (2017-2022)
12.2 China Antiandrogen Monotherapy Production, Consumption Forecast by Regions (2017-2022)
12.3 China Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
12.4 China Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)
12.5 Antiandrogen Monotherapy Price Forecast (2017-2022)
CHAPTER 13 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Antiandrogen Monotherapy
Figure China Production Market Share of Antiandrogen Monotherapy by Type in 2016
Table Antiandrogen Monotherapy Consumption Market Share by Application in 2016
Figure China Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Table China Antiandrogen Monotherapy Capacity of Key Manufacturers (2015 and 2016)
Table China Antiandrogen Monotherapy Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Antiandrogen Monotherapy Capacity of Key Manufacturers in 2015
Figure China Antiandrogen Monotherapy Capacity of Key Manufacturers in 2016
Table China Antiandrogen Monotherapy Production of Key Manufacturers (2015 and 2016)
Table China Antiandrogen Monotherapy Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Production Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Production Share by Manufacturers
Table China Antiandrogen Monotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 China Antiandrogen Monotherapy Revenue Share by Manufacturers
Table China Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2016
Table Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Antiandrogen Monotherapy Product Type
Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers
Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Antiandrogen Monotherapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Antiandrogen Monotherapy Market Share (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Share (2012-2017)
Figure Production Revenue Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure 2015 Revenue Market Share of Antiandrogen Monotherapy by Type
Table China Antiandrogen Monotherapy Price by Type (2012-2017)
Figure China Antiandrogen Monotherapy Production Growth by Type (2012-2017)
Table China Antiandrogen Monotherapy Consumption by Application (2012-2017)
Table China Antiandrogen Monotherapy Consumption Market Share by Application (2012-2017)
Figure China Antiandrogen Monotherapy Consumption Market Share by Application in 2016
Table China Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
Figure China Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure China Antiandrogen Monotherapy Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Table China Antiandrogen Monotherapy Production, Import, Export and Consumption Forecast (2017-2022)
Table China Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
Table China Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)
ALZA Corporation (USA)
Amgen Inc. (USA)
AstraZeneca PLC (UK)
Medimmune, LLC (USA)
Bristol-Myers Squibb Company (USA)
Cell Genesys Inc. (USA)
Dendreon Corporation (USA)
EUSA Pharma, (USA) Inc. (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Progenics Pharmaceuticals, Inc. (USA)
Sanofi-Aventis SA (France)
Spectrum Pharmaceuticals, Inc. (USA)
Takeda Pharmaceutical Company Limited (Japan)
Figure Picture of Antiandrogen Monotherapy
Figure China Production Market Share of Antiandrogen Monotherapy by Type in 2016
Table Antiandrogen Monotherapy Consumption Market Share by Application in 2016
Figure China Antiandrogen Monotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Table China Antiandrogen Monotherapy Capacity of Key Manufacturers (2015 and 2016)
Table China Antiandrogen Monotherapy Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Antiandrogen Monotherapy Capacity of Key Manufacturers in 2015
Figure China Antiandrogen Monotherapy Capacity of Key Manufacturers in 2016
Table China Antiandrogen Monotherapy Production of Key Manufacturers (2015 and 2016)
Table China Antiandrogen Monotherapy Production Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Production Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Production Share by Manufacturers
Table China Antiandrogen Monotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 China Antiandrogen Monotherapy Revenue Share by Manufacturers
Table China Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2016
Table Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Antiandrogen Monotherapy Product Type
Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers
Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Antiandrogen Monotherapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Antiandrogen Monotherapy Market Share (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Share (2012-2017)
Figure Production Revenue Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure 2015 Revenue Market Share of Antiandrogen Monotherapy by Type
Table China Antiandrogen Monotherapy Price by Type (2012-2017)
Figure China Antiandrogen Monotherapy Production Growth by Type (2012-2017)
Table China Antiandrogen Monotherapy Consumption by Application (2012-2017)
Table China Antiandrogen Monotherapy Consumption Market Share by Application (2012-2017)
Figure China Antiandrogen Monotherapy Consumption Market Share by Application in 2016
Table China Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
Figure China Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure China Antiandrogen Monotherapy Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Table China Antiandrogen Monotherapy Production, Import, Export and Consumption Forecast (2017-2022)
Table China Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
Table China Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)
ALZA Corporation (USA)
Amgen Inc. (USA)
AstraZeneca PLC (UK)
Medimmune, LLC (USA)
Bristol-Myers Squibb Company (USA)
Cell Genesys Inc. (USA)
Dendreon Corporation (USA)
EUSA Pharma, (USA) Inc. (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Progenics Pharmaceuticals, Inc. (USA)
Sanofi-Aventis SA (France)
Spectrum Pharmaceuticals, Inc. (USA)
Takeda Pharmaceutical Company Limited (Japan)